Risk Of Developing Liver Cancer After HCV Treatment

▼
Showing posts with label Viekira XR. Show all posts
Showing posts with label Viekira XR. Show all posts
Monday, November 12, 2018

Adolescents HCV Geno 1 or 4 -.Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir and With/Without Ribavirin

›
In Case You Missed It Hepatol Commun . 2018 Nov; 2(11): 1311–1319. Published online 2018 Oct 5. doi: [ 10.1002/hep4.1250 ] Ombitasvir/P...
Wednesday, October 17, 2018

Shortened Therapy of Eight Weeks With Paritaprevir/ritonavir/Ombitasvir and Dasabuvir Is Highly Effective in People With Recent HCV Genotype 1 Infection

›
Is an 8-week therapy of paritaprevir/ritonavir/ombitasvir and dasabuvir + ribavirin as effective as the standard 12-week regimen in individu...
Friday, August 24, 2018

Treatment in HCV genotype 1b patients with advanced fibrosis and cirrhosis

›
PLoS One. 2018 Aug 23;13(8):e0202777. doi: 10.1371/journal.pone.0202777.  Hepatic decompensation during paritaprevir/ritonavir/ombitas...
Thursday, May 24, 2018

Hepatitis C Virus Infection Treatments to Be Discontinued:Technivie, Viekira XR and Simeprevir

›
In Case You Missed It FDA Website: https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm?panels=0&#tabs-4 Also disconti...
Wednesday, January 10, 2018

Effect of ombitasvir/paritaprevir/ritonavir + dasabuvir regimen on health-related quality of life for patients with hepatitis C

›
Liver International  Accepted Article Effect of ombitasvir/paritaprevir/ritonavir + dasabuvir regimen on health-related quality of li...
Wednesday, October 11, 2017

Hepatitis C Treatment With Direct-Acting Antivirals Confers Survival Benefit

›
In Case You Missed It Today over at Infectious Disease Advisor , media coverage on the study ; Effect of Paritaprevir/Ritonavir/Ombitasv...
Saturday, August 26, 2017

The new paradigm in the treatment of chronic hepatitis C disease: Faster, Higher and Stronger

›
Citius Altius Fortius: The new paradigm in the treatment of chronic hepatitis C disease George M Abraham, MD, MPH   ...
Wednesday, August 16, 2017

Hepatitis C - DAAs reduces the risk of mortality in the first 18 months after the completion of treatment

›
Source - infohep Treatment with DAAs reduces the risk of mortality in the first 18 months after the completion of treatment Michael Car...
Saturday, May 27, 2017

May 2017 - Hepatitis C in a New Era: A Review of Current Therapies

›
P T. 2017;42(5) : 316-329 Hepatitis C in a New Era: A Review of Current Therapies Troy Kish PharmD, BCPS Andrew Aziz PharmD ...